Mendus

8 clinical trials · Sponsor

Record	Firm	Date
Phase I Trial of Vididencel in CML-CP Patients With MRD Under TKI Treatment (NCT07651878)	Mendus	2026-04-14
A Study to Evaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With Checkpoint Inhibitor (CPI) in Patients With ADvanced Cancer (NCT03735290)	Mendus	2019-01-14
Efficacy and Safety of Immunotherapy With Allogeneic Dendritic Cells, DCP-001, in Patients With Acute Myeloid Leukaemia (NCT03697707)	Mendus	2018-10-15

Every clearance here is in the API, with alerts when new ones post.